Evidence map›Paper›PMID 42560937›Full record

ReviewAnnals of nutrition & metabolism2026

Carrageenan: Food Additive or Health Concern? A Comprehensive Review.

Sedat Arslan, Merve Kiyar, İpek Akyüz, Oumaima Afailal, Rumeysa Nur Sari, Moutessim Hassan Zİber, Ayça Aydin

Abstract readReview
In one paragraph

Review in Annals of nutrition & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sedat ArslanDepartment of Nutrition and Dietetics, Bursa Uludag University, Bursa, Turkey, sedatarslan@uludag.edu.tr.
Merve KiyarDepartment of Nutrition and Dietetics, Bandirma Onyedi Eylul University, Balikesir, Turkey.
İpek AkyüzDepartment of Nutrition and Dietetics, Bandirma Onyedi Eylul University, Balikesir, Turkey.
Oumaima AfailalDepartment of Nutrition and Dietetics, Bandirma Onyedi Eylul University, Balikesir, Turkey.
Rumeysa Nur SariDepartment of Nutrition and Dietetics, Bandirma Onyedi Eylul University, Balikesir, Turkey.
Moutessim Hassan ZİberDepartment of Nutrition and Dietetics, Bandirma Onyedi Eylul University, Balikesir, Turkey.
Ayça AydinDepartment of Nutrition and Dietetics, Istanbul Okan University, Istanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCarrageenan, a sulfated polysaccharide extracted from red seaweeds, is widely used in the food, pharmaceutical, and cosmetic industries due to its gelling, thickening, and stabilizing properties. SUMMARY: Its widespread use in the Western diet and processed foods has raised scientific interest regarding its health effects. Evidence remains contradictory: some studies report antioxidant, antiviral, antitumor, and immunomodulatory benefits, whereas others suggest potential adverse outcomes, including impaired glucose metabolism, intestinal inflammation, and immune dysregulation. These effects appear to depend on carrageenan type, molecular weight, purity, dosage, and host-related factors. Regulatory bodies such as the FDA and EFSA generally consider carrageenan safe, although concerns remain regarding infant formulas and long-term exposure. KEY MESSAGES: Carrageenan cannot be uniformly classified as beneficial or harmful. Its biological effects are context-specific, and further well-designed clinical and mechanistic studies are needed to clarify dose-response relationships, safety in vulnerable populations, and implications for industry and public health nutrition.

Indexed as

CarrageenanDietary safetyFood additiveInflammationPolysaccharides

Identifiers

PMID42560937
PMCPMC13446871

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.